The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Open accessAbstract
Acetyl coenzyme A (AcCoA) is the central biosynthetic precursor for fatty-acid synthesis and protein acetylation. In the conventional view of mammalian cell metabolism, AcCoA is primarily generated from glucose-derived pyruvate through the citrate shuttle and ATP citrate lyase in the cytosol. However, proliferating cells that exhibit aerobic glycolysis and those exposed to hypoxia convert glucose to lactate at near-stoichiometric levels, directing glucose carbon away from the tricarboxylic acid cycle and fatty-acid synthesis. Although glutamine is consumed at levels exceeding that required for nitrogen biosynthesis, the regulation and use of glutamine metabolism in hypoxic cells is not well understood. Here we show that human cells use reductive metabolism of α-ketoglutarate to synthesize AcCoA for lipid synthesis. This isocitrate dehydrogenase-1 (IDH1)-dependent pathway is active in most cell lines under normal culture conditions, but cells grown under hypoxia rely almost exclusively on the reductive carboxylation of glutamine-derived α-ketoglutarate for de novo lipogenesis. Furthermore, renal cell lines deficient in the von Hippel-Lindau tumour suppressor protein preferentially use reductive glutamine metabolism for lipid biosynthesis even at normal oxygen levels. These results identify a critical role for oxygen in regulating carbon use to produce AcCoA and support lipid synthesis in mammalian cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both HIF-1α and HIF-2α activation promotes the upregulation of the glutamine transporter, SLC38A2, which increases the dependency of cells to glutamine and correlates with poorer survival in patients with breast cancer [58]”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [631]
In the citing paper
“Citrate, generated by reductive carboxylation of α-KG, is especially crucial for lipid synthesis under low-oxygen conditions24,25.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [24]
In the citing paper
“and switch the fate of glutamine from the oxidative pathway into the reductive carboxylation pathway24.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [24]
In the citing paper
“Glutamine acts as an alternative fuel for fatty acid synthesis, supplying citrate via mitochondrial reductive carboxylation, especially under hypoxic conditions74,75.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [75]
In the citing paper
“Alternatively, proliferating cells under hypoxia have been reported to predominantly reductively carboxylate glutamine generated α-ketoglutarate through IDH 1/2 to generate M5 citrate (Figure 4A) (Metallo, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Metallo, 2012
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Metallo, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Metallo, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [122]
In the citing paper
“In a process referred to as reductive carboxylation, a section of the TCA cycle reverses itself, converting α-ketoglutarate into citrate, which can be then used to generate a source of cytosolic acetyl-CoA (Metallo et al., 2012; Wise et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Metallo et al., 2012
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [79]
In the citing paper
“Citrate levels, however, were markedly decreased in Mpc1KD or Mpc2KD (Mpc1/2KD) cells, as this metabolite is generated predominantly from pyruvate-derived AcCoA under normal growth conditions (Metallo et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Metallo et al., 2012
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Metallo et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Metallo et al., 2012
In the citing paper
“This switch to reductive versus oxidative metabolism of α-KG is regulated in part by HIF-1α (71, 72), although the exact mechanism by which HIF-1α does so remains unclear.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [71]
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [71]
In the citing paper
“The work from Metallo and colleagues (71) suggests that T cells can use reductive glutamine metabolism for fatty acid biosynthesis under hypoxic conditions.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [71]
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Metallo et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Metallo et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Metallo et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“The von Hippel–Lindau (VHL) tumour suppressor protein is frequently lost in renal cell carcinoma (RCC) and results in a state of ‘pseudohypoxia’ by activating HIF signallin”
BackgroundKim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
T cell receptor antagonist peptides induce positive selection.
Hogquist, K., Jameson, S., Heath, W., Howard, J. L., Bevan, M., & Carbone, F. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 3,252
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Cited by
Sorted by citations
Items 801–900 of 1,003
Ryoo, I., Kwon, H. N., Kim, S. C., Jung, S. C., Yeom, J. A., Shin, H. S., Cho, H. R., Yun, T. J., Choi, S. H., Sohn, C., et al. (2016) · Scientific Reports · doi:10.1038/srep30075 · Cited by 43
A Metabolic Paradigm for Hydrogen Sulfide Signaling via Electron Transport Chain Plasticity
Hanna, D. A., Kumar, R., & Banerjee, R. V. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0067 · Cited by 45
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
Khan, F., Elsori, D. H., Verma, M., Pandey, S., Rab, S. O., Siddiqui, S., Alabdallah, N. M., Saeed, M., & Pandey, P. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1399065 · Cited by 45
Botman, D., Tigchelaar, W., & Noorden, C. J. F. V. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414551177 · Cited by 41
Non‐stationary 13C‐metabolic flux ratio analysis
Hörl, M., Schnidder, J., Sauer, U., & Zamboni, N. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.25004 · Cited by 42
Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
Wang, J., Ye, W., Yan, X., Guo, Q., Ma, Q., Lin, F., Huang, J., & Jin, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1884-5 · Cited by 43
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42
The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation
Acuña-Pilarte, K., & Koh, M. Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.06.005 · Cited by 64
Microglia and Brain Macrophages as Drivers of Glioma Progression
Zheng, Y., & Graeber, M. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415612 · Cited by 40
Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy
Liu, Z., Wang, R., Wang, Y., Duan, Y., & Zhan, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115713 · Cited by 43
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
Choate, K. A., Pratt, E. P. S., Jennings, M. J., Winn, R. J., & Mann, P. B. (2024) · Biology · doi:10.3390/biology13110885 · Cited by 49
Oncogenes strike a balance between cellular growth and homeostasis
Qiu, B., & Simon, M. C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.005 · Cited by 44
Zhou, J., Deng, Z., Chen, Y., Gao, Y., Wu, D., Zhu, G., Li, L., Song, W., Wang, X., Wu, K., et al. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.08.001 · Cited by 41
Cancer metabolism as a central driving force of glioma pathogenesis
Masui, K., Cavenee, W. K., & Mischel, P. S. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0265-5 · Cited by 40
Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer
Zhu, X., Wang, K., Liu, G., Wang, Y., Xu, J., Liu, L., Li, M., Shi, J., Aa, J., & Lianzhen, Y. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/5469597 · Cited by 41
PKM2 promotes reductive glutamine metabolism
Miao, L., Yuanyuan, W., Yuxia, R., Changsen, B., Li, Q., Yanfen, C., Guoguang, Y., & Binghui, L. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0122 · Cited by 42
Takashima, Y., Hayano, A., & Yamanaka, R. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3851 · Cited by 39
Extracellular Citrate Fuels Cancer Cell Metabolism and Growth
Haferkamp, S., Drexler, K., Federlin, M., Schlitt, H. J., Berneburg, M., Adamski, J., Gaumann, A. K. A., Geissler, E. K., Ganapathy, V., Parkinson, E. K., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602476 · Cited by 44
Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease
Baliga, M. M., Klawitter, J., Christians, U., Hopp, K., Chonchol, M., Gitomer, B. Y., Cadnapaphornchai, M. A., & Klawitter, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-84609-8 · Cited by 41
Johnson, R. L., Cummings, M., Thangavelu, A., Theophilou, G., Jong, D. D., & Orsi, N. M. (2021) · Cancers · doi:10.3390/cancers13246231 · Cited by 39
Williams, A. C., Hill, L. J., & Ramsden, D. B. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/302875 · Cited by 42
De Palma, S., Capitanio, D., Vasso, M., Braghetta, P., Scotton, C., Bonaldo, P., Lochmüller, H., Muntoni, F., Ferlini, A., & Gelfi, C. (2014) · Journal of Proteome Research · doi:10.1021/pr500675e · Cited by 40
Measurement of lipogenic flux by deuterium resolved mass spectrometry
Fu, X., Deja, S., Fletcher, J. A., Anderson, N. N., MIZERSKA, M. N., do Vale, G. D., Browning, J. D., Horton, J. D., McDonald, J. G., Mitsche, M. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23958-4 · Cited by 40
Metabolic Relationship Between Cancer-Associated Fibroblasts and Cancer Cells
Sazeides, C., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_14 · Cited by 41
Metabolic advantages of regulatory T cells dictated by cancer cells
Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 42
Trejo‐Solís, C., Silva‐Adaya, D., Serrano-García, N., Magaña-Maldonado, R., Jiménez‐Farfán, D., Ferreira-Guerrero, E., Cruz-Salgado, A., & Castillo‐Rodríguez, R. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417633 · Cited by 44
Previs, S. F., McLaren, D. G., Wang, S.-P., Stout, S. J., Zhou, H., Herath, K. B., Shah, V., Miller, P. L., Wilsie, L. C., Castro‐Perez, J. M., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.019 · Cited by 40
Inferring Metabolic States in Uncharacterized Environments Using Gene-Expression Measurements
Rossell, S., Huynen, M. A., & Notebaart, R. A. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002988 · Cited by 41
Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
Smolková, K., Dvořák, A., Zelenka, J., Vı́tek, L., & Ježek, P. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.012 · Cited by 39
Sun, H.-W., Wu, W., Chen, H., Xu, Y.-T., Yang, Y., Chen, J., Yu, X.-J., Wang, Z., Shuang, Z., & Zheng, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616367 · Cited by 40
Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer
Hur, H., Kim, Y., Ham, I., & Lee, D. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24043 · Cited by 40
The role of HIF-1 in oncostatin M-dependent metabolic reprogramming of hepatic cells
Battello, N., Zimmer, A. D., Goebel, C., Dong, X., Behrmann, I., Haan, C., Hiller, K., & Wegner, A. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0141-0 · Cited by 40
Self-citationMitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression
Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 44
Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress
Tang, Y., Zhang, Z., Chen, Y., Qin, S., Zhou, L., Gao, W., & Shen, Z. (2022) · Antioxidants · doi:10.3390/antiox11071324 · Cited by 47
100 years of the Warburg effect: a historical perspective
Hardie, D. G. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0173 · Cited by 43
The role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 39
Darpolor, M. M., Basu, S. S., Worth, A., NELSON, D. S., Katzenberg, R. H., Glickson, J. D., Kaplan, D. E., & Blair, I. A. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3072 · Cited by 39
Mapping cancer cell metabolism with 13 C flux analysis: Recent progress and future challenges
Young, J., Duckwall, C., & Murphy, T. A. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.115422 · Cited by 43
Sener, Z., Cederkvist, F. H., Volchenkov, R., Holen, H. L., & Skålhegg, B. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160291 · Cited by 39
Lee, H.-C., Lin, S., Wu, M., & Tsai, S. (2018) · Reproductive Sciences · doi:10.1177/1933719118789513 · Cited by 42
Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension
Suliman, H. B., & Nozik‐Grayck, E. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7705 · Cited by 38
Joly, J. H., Lowry, W. E., & Graham, N. A. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa658 · Cited by 41
Cancer-associated cells release citrate to support tumour metastatic progression
Drexler, K., Schmidt, K. M., Jordan, K., Federlin, M., Milenkovic, V. M., Liebisch, G., Artati, A., Schmidl, C., Madej, M. G., Tokarz, J., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000903 · Cited by 39
Clinical development of IDH1 inhibitors for cancer therapy
Zarei, M., Hue, J. J., Hajihassani, O., Graor, H. J., Katayama, E., Loftus, A. W., Bajor, D. L., Rothermel, L. D., Gohar, A. V., & Winter, J. M. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102334 · Cited by 39
The Warburg effect: The hacked mitochondrial-nuclear communication in cancer
Jiang, H., & Ye, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.006 · Cited by 40
IDH1, lipid metabolism and cancer: Shedding new light on old ideas
Bogdanovic, E. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.04.014 · Cited by 39
Rodrigues, D., Monteiro, M. S., Jerónimo, C., Henrique, R., Belo, L., Bastos, M. D. L., de Pinho, P. G., & Carvalho, M. C. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.018 · Cited by 38
Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells
Viswanath, P., Chaumeil, M. M., & Ronen, S. M. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00060 · Cited by 38
Samuel, S. M., Ghosh, S., Majeed, Y., Arunachalam, G., Emara, M. M., Ding, H., & Triggle, C. R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.001 · Cited by 37
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0117 · Cited by 39
Sainero‐Alcolado, L., Garde-Lapido, E., Snaebjornsson, M. T., Schoch, S., Stevens, I., Ruiz-Pérez, M. V., Dyrager, C., Pelechano, V., Axelson, H., Schulze, A., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2310479121 · Cited by 36
Wynn, M. L., Yates, J. A., Evans, C. R., Wassenhove, L. D. V., Wu, Z.-F., Bridges, S., Bao, L., Fournier, C. L., Ashrafzadeh, S., Merrins, M. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703959 · Cited by 37
Lopes‐Coelho, F., Gouveia-Fernandes, S., & Serpa, J. (2018) · Tumor Biology · doi:10.1177/1010428318756203 · Cited by 39
The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells
Antonosante, A., d’Angelo, M., Castelli, V., Catanesi, M., Iannotta, D., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071907 · Cited by 37
Glutamine uptake and utilization of human mesenchymal glioblastoma in orthotopic mouse model
Oizel, K., Yang, C., Renoult, O., Gautier, F., Do, Q. N., Joalland, N., Gao, X., Ko, B., Vallette, F. M., Ge, W., et al. (2020) · Cancer & Metabolism · doi:10.1186/s40170-020-00215-8 · Cited by 37
Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer
Shah, R., & Chen, S. (2020) · Cancers · doi:10.3390/cancers12092624 · Cited by 36
Tong, Y., Kai, J., Wang, S., Yu, Y., Xie, S., Zheng, H., Wang, Y., Liu, Y., Zhu, K., Guan, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03901-7 · Cited by 37
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 38
Targeting of chimeric antigen receptor T cell metabolism to improve therapeutic outcomes
Nanjireddy, P., Olejniczak, S. H., & Buxbaum, N. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1121565 · Cited by 39
Liang, P., Li, Z., Chen, Z., Chen, Z., Jin, T., He, F., Chen, X., Gou, H., & Yang, K. (2025) · The FASEB Journal · doi:10.1096/fj.202403019r · Cited by 42
Joshi, S., Liu, M., & Turner, N. A. (2015) · BioMed Research International · doi:10.1155/2015/390863 · Cited by 36
Cancer metabolism and mass spectrometry-based proteomics
Zhou, W., Liotta, L. A., & Petricoin, E. F. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.003 · Cited by 38
Replication of the Shrimp Virus WSSV Depends on Glutamate-Driven Anaplerosis
Li, C.-Y., Wang, Y.-J., Huang, S.-W., Cheng, C.-S., & Wang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146902 · Cited by 37
He, S.-T., Lee, D.-Y., Tung, C.-Y., Li, C.-Y., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02102 · Cited by 37
Bouthelier, A., & Aragonés, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118733 · Cited by 37
Peltomaa, A. I., Raittinen, P. V. H., Talala, K. M., Taari, K., Tammela, T. L. J., Auvinen, A. P., & Murtola, T. J. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00351-2 · Cited by 36
Shi, Y., Wang, S., Yang, R., Wang, Z., Zhang, W., Liu, H., & Huang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1084006 · Cited by 36
Discoveries, therapies and opportunities
Linehan, W. M., & Ricketts, C. J. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.262 · Cited by 35
Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP‐1
Zhang, Y., Li, C., Hu, C., Wu, Q., Cai, Y., Xing, S., Lu, H. J., Wang, L., Huang, D., Sun, L., et al. (2019) · EMBO Reports · doi:10.15252/embr.201948115 · Cited by 35
Alptekin, A., Ye, B., Yu, Y., Poole, C. J., van Riggelen, J., Zha, Y., & Ding, H. (2019) · Oncogene · doi:10.1038/s41388-019-0967-3 · Cited by 35
Urra, F. A., Fuentes-Retamal, S., Palominos, C., Rodríguez-Lucart, Y. A., López-Torres, C., & Araya‐Maturana, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751301 · Cited by 38
Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders
Serpa, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_1 · Cited by 35
The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
Liu, Y., Xu, W., Li, M., Yang, Y., Sun, D., Chen, L., Li, H., & Chen, L. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.019 · Cited by 37
PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma
Peng, S., Wang, Z., Tang, P., Wang, S., Huang, Y., Xie, Q., Wang, Y., Tan, X., Tang, T., Yan, X., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf3566 · Cited by 38
Glutaminase inhibition as potential cancer therapeutics: current status and future applications
Cyriac, R., & Lee, K. (2023) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2023.2290911 · Cited by 38
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Li, J., Yu., T. S., Zeng, P., Tian, J., Liu, P., Qiao, S., Wen, S., Hu, Y., Liu, Q., Lu, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47536-6 · Cited by 38
Unraveling Biochemical Pathways Affected by Mitochondrial Dysfunctions Using Metabolomic Approaches
Demine, S., Reddy, N., Renard, P., Raes, M. J., & Arnould, T. (2014) · Metabolites · doi:10.3390/metabo4030831 · Cited by 37
Metabolism, longevity and epigenetics
Cosentino, C., & Mostoslavsky, R. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1295-3 · Cited by 35
Capitanio, D., Fania, C., Torretta, E., Viganò, A., Moriggi, M., Bravatà, V., Caretti, A., Levett, D. Z. H., Grocott, M. P. W., Samaja, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10097-4 · Cited by 35
A Metabolomics Study of BPTES Altered Metabolism in Human Breast Cancer Cell Lines
Gowda, G. A. N., Barding, G. A., Dai, J., Gu, H., Margineantu, D. H., Hockenbery, D. M., & Raftery, D. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00049 · Cited by 34
Profiling the Metabolism of Human Cells by Deep 13C Labeling
Grankvist, N., Watrous, J. D., Lagerborg, K. A., Lyutvinskiy, Y., Jain, M., & Nilsson, R. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.09.004 · Cited by 32
Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
Martins, F., Gonçalves, L. G., Pojo, M., & Serpa, J. (2020) · Biomolecules · doi:10.3390/biom10101370 · Cited by 35
Kuramoto, K., Yamamoto, M., Suzuki, S., Togashi, K., Sanomachi, T., Kitanaka, C., & Okada, M. (2021) · Genes · doi:10.3390/genes12010099 · Cited by 34
Fu, L. N., Zhang, L., Liu, L., Yang, H., Zhou, P., Song, F., Dong, G., Chen, J., Wang, G., & Dong, X. (2021) · Animals · doi:10.3390/ani11113153 · Cited by 34
USP13: Multiple Functions and Target Inhibition
Li, X., Yang, G. H., Zhang, W., Qin, B., Ye, Z., Shi, H., Zhao, X., Chen, Y., Song, B., Mei, Z., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.875124 · Cited by 34
Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities
Wang, H., Wang, W., & Fan, S. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70292 · Cited by 34
Warburg and Krebs and related effects in cancer
Unterlass, J. E., & Curtin, N. J. (2019) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2019.4 · Cited by 35
Mitochondria and CancerPreprint
Kenny, T. C., & Birsoy, K. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041534 · Cited by 40
Ianni, N. D., Musio, S., & Pellegatta, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094460 · Cited by 34
Integrated Control of Fatty Acid Metabolism in Heart Failure
Li, X., & Bi, X. (2023) · Metabolites · doi:10.3390/metabo13050615 · Cited by 34
Hypoxia tolerance in fish depends on catabolic preference between lipids and carbohydrates
Ma, Q., 华东师范大学生命科学学院水生动物营养与环境健康实验室, 上. 2., Luo, Y., Zhong, J., Limbu, S. M., Li, L.-Y., Chen, L., Qiao, F., Zhang, M., Lin, Q., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.098 · Cited by 36
Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation
Castillo, C., Grieco, M., D’Amone, S., Lolli, M. G., Ursini, O., & Cortese, B. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216792 · Cited by 36
Zooming-in on cancer metabolic rewiring with tissue specific constraint-based models
Filippo, M. D., Colombo, R., Damiani, C., Pescini, D., Gaglio, D., Vanoni, M., Alberghina, L., & Mauri, G. (2016) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2016.03.002 · Cited by 32
Neomorphic mutations create therapeutic challenges in cancer
Takiar, V., Ip, C. K. M., Gao, M., Mills, G. B., & Cheung, L. W. T. (2016) · Oncogene · doi:10.1038/onc.2016.312 · Cited by 33
Learning from quantitative data to understand central carbon metabolism
Matsuda, F., Toya, Y., & Shimizu, H. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.09.006 · Cited by 33
T-Cell Metabolism in Hematopoietic Cell Transplantation
Nguyen, H. D., Kuril, S., Bastian, D. A., & Yu, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00176 · Cited by 34
Carballal, S., Vitvitsky, V., Kumar, R., Hanna, D. A., Libiad, M., Gupta, A., Jones, J. W., & Banerjee, R. V. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100950 · Cited by 34
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
Stable Isotope Tracer Analysis in Isolated Mitochondria from Mammalian Systems
Gravel, S., Andrzejewski, S., Avizonis, D. Z., & St‐Pierre, J. (2014) · Metabolites · doi:10.3390/metabo4020166 · Cited by 37
Sá, J. V., Kleiderman, S., Brito, C., Sonnewald, U., Leist, M., Teixeira, A. P., & Alves, P. M. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1907-z · Cited by 33
Metadata
- Authors
- Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., Kelleher, J. K., Vander Heiden, M. G., Iliopoulos, O., & Stephanopoulos, G.
- Affiliations
- Massachusetts Institute of Technology (US)
- Massachusetts General Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Iliopoulos, Othon
- Stephanopoulos, Gregory
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3710581
- OpenAlex
- W2116516144
- Cited by
- 1,791
- References
- 43
- Citations by year
- 2026: 82 · 2025: 95 · 2024: 96 · 2023: 137 · 2022: 156 · 2021: 143 · 2020: 149 · 2019: 125 · 2018: 100 · 2017: 135 · 2016: 129 · 2015: 125 · 2014: 119 · 2013: 112 · 2012: 84
- FWCI
- 34.61
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Damon Runyon Cancer Research Foundation
- Wellcome Trust
- Agios Pharmaceuticals
- National Institutes of Health
- National Cancer Institute (R01CA160458, R01CA122591, P30CA014051)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK075850)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- IDH1, lipogenesis, hypoxia, reductive carboxylation, alpha-ketoglutarate, acetyl-CoA, fatty acid synthesis, VHL, renal cell carcinoma, cancer metabolism, mitochondrial dysfunction, aerobic glycolysis
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Acetyl Coenzyme A, Carbon, Carcinoma, Renal Cell, Cells, Cultured, Citric Acid Cycle, Glutamine, Humans, Isocitrate Dehydrogenase, Ketoglutaric Acids, Kidney Neoplasms, Oxidation-Reduction, Oxygen, Cell Hypoxia, CD8-Positive T-Lymphocytes, Palmitic Acid, Cell Line, Tumor, Lipogenesis, Aryl Hydrocarbon Receptor Nuclear Translocator, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
